Vendor, Framingham, MA
Cyprotex US LLC
UEI YNGLSAF57T14, CAGE 47UC6
16 awards and $659,129 obligated between February 1, 2024 and October 8, 2026, 31% under full and open competition, against 1.3 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Departmental Offices | $496,160 |
| Food and Drug Administration | $70,500 |
| Environmental Protection Agency | $50,000 |
| National Institutes of Health | $42,469 |
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $496,160 |
| Testing Laboratories and ServicesNAICS 541380 | $98,439 |
| Other Scientific and Technical Consulting ServicesNAICS 541690 | $70,500 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | -$5,970 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 6 |
| Full and Open Competition | 5 |
| Competed Under SAP | 3 |
| Not Competed | 2 |
| Purchase Order | 11 |
| Delivery Order | 4 |
Hear when Cyprotex US LLC wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Cyprotex US LLC holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 1
- Obligated so far
- $77,897
- Soonest
- July 14, 2027
The 1 contract, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to Departmental Offices, by dollars.
| Global Secure Shipping Inc.Old Town, ME | $12,676,526 |
| SNC Therapeutics, Inc.Evanston, IL | $6,997,810 |
| Boundless Science Inc.Chapel Hill, NC | $6,900,833 |
| Rydberg Technologies Inc.Ann Arbor, MI | $6,300,496 |
| Zigguratum, Inc.Chattanooga, TN | $5,851,904 |
| Hypercomp Inc.Thousand Oaks, CA | $5,292,228 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- In vitro testing services for small-molecule drug candidates
National Institutes of Health, National Institutes of Health Olao
PresolicitationNAICS 541380Bethesda, MD75N98026Q00482Awarded to Cyprotex US LLC
Posted May 29 - EPA High Throughput Toxicokinetics (HTTK)
Departmental Offices, Ibc Acq SVCS Directorate
Award noticeNAICS 541715Massachusetts140D0424F0309Awarded to Cyprotex US LLC for $44,744
Posted Feb 9, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 140D0425F0082Delivery Order, December 23, 2024, Full and Open Competition | Ibc Acq SVCS DirectorateDepartmental Offices | High Throughput Toxicokinetics (Httk) - Task Order #7NAICS 541715, PSC B504 | $451,818 |
| 75N98026P00718Purchase Order, June 9, 2026, Not Competed, 1 offersSolicitation | National Institutes of Health OlaoNational Institutes of Health | Nci: Service: in Vitro Drug Candidate Testing: Non-SeverableNAICS 541380, PSC Q301 | $77,897 |
| 75F40126P00176Purchase Order, August 10, 2026, Not Competed, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Eo 14398 - Purchase of Development of a Human Neural Network Formation New Approach Method for the Evaluation of Potential Developmental NeuNAICS 541690, PSC B599 | $70,500 |
| 68HE0B25P0230Purchase Order, February 3, 2025, Not Competed Under SAP, 1 offers | Ord Simplified Acq Branch (Sab)Environmental Protection Agency | Testing of Compounds in Human Neurite Outgrowth Assay (Adme-Tox Services)NAICS 541380, PSC B599 | $50,000 |
| 140D0424F0309Delivery Order, February 2, 2024, Full and Open CompetitionSolicitation | Ibc Acq SVCS DirectorateDepartmental Offices | EPA -Toxicokinetic TestingNAICS 541715, PSC B504 | $44,744 |
| 68HE0B23P0636Purchase Order, July 31, 2024, Competed Under SAP, 1 offers | Ord Simplified Acq Branch (Sab)Environmental Protection Agency | Unilateral Modification P00001 to Po # 68he0b23p0636 to Extend Ending Pop. Testing Chemicals in Network Formation AssayNAICS 541715, PSC B504 | $0 |
| 140D0420D0003September 20, 2024, Full and Open Competition, 2 offersSolicitation | Ibc Acq SVCS DirectorateDepartmental Offices | High Throughput Toxicokinetics (Httk). Adds a Clause to the Contract.NAICS 541715, PSC B504 | $0 |
| 75N95020P00056Purchase Order, September 10, 2025, Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Testing of 100 Compounds for Cyp InhibitionNAICS 541380, PSC Q301 | -$60 |
| 140D0424F0076Delivery Order, November 14, 2024, Full and Open Competition | Ibc Acq SVCS DirectorateDepartmental Offices | EPA -Toxicokinetic Testing- Extension of Period of Performance End DateNAICS 541715, PSC B504 | -$168 |
| 140D0423F0254Delivery Order, February 1, 2024, Full and Open Competition | Ibc Acq SVCS DirectorateDepartmental Offices | High Throughput Toxicokinetics (Httk) Task Order #4NAICS 541715, PSC B504 | -$234 |
| 75N95023P00020Purchase Order, May 22, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative - Testing of Compounds in Caco-2 AssaysNAICS 541380, PSC Q301 | -$280 |
| 75N95022P00601Purchase Order, May 21, 2026, Competed Under SAP, 4 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative - Testing of Compounds in Cyp Inhibition, Herg Inhibition, Ppb, and Caco-2 Permeability AssaysNAICS 541380, PSC Q301 | -$738 |
| 75N95020P00597Purchase Order, September 16, 2025, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541990, PSC Q301 | -$5,970 |
| 75N95021P00593Purchase Order, September 14, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541380, PSC Q301 | -$7,830 |
| 75N95019P00369Purchase Order, February 21, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Bioanalysis Testing ServicesNAICS 541380, PSC Q301 | -$8,430 |
| 75N95021P00105Purchase Order, September 16, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541380, PSC Q301 | -$12,120 |
- Places of performance
- Massachusetts
- Product and service codes
- B504 Chemical/Biological Studies and AnalysisB599 Other Special Studies and AnalysisQ301 Reference Laboratory Testing
- Transactions
- 31 across 16 awards